Creatine for Brain Health: What It Does for Memory and Focus

Metabolic Health · Brain Bioenergetics

The supplement most people take for their legs has better human brain imaging data behind it than almost anything sold as a nootropic. Almost nobody taking it is dosing it for the brain.

Creatine can support brain health because it acts as an energy buffer in the brain, helping regenerate ATP quickly in cells with high energy demand. In human studies, brain creatine levels can measurably rise, and cognitive benefits show up most clearly when the brain is under stress from aging, sleep loss, or other energy strain. Creatine is filed in the public mind under muscle. That is a category error, and it is the reason a compound with four decades of human safety data and direct brain imaging evidence is still marketed almost exclusively to people who want a bigger bench press.

Creatine is not a muscle compound. It is an energy buffer. It exists to hold phosphate groups in reserve so that ATP can be regenerated instantly, at the exact location where it is being spent, faster than mitochondria can produce it. Muscle happens to be a tissue with enormous, intermittent energy demand. So is the brain. The human brain is roughly 2 percent of body weight and consumes about 20 percent of resting energy expenditure. Per gram, nothing else in the body costs more to run.

For adults interested in brain health, cognitive support, and metabolic resilience, particularly those 40 and older trying to make evidence-based decisions about supplementation, the practical question is not whether creatine is "good for the brain" in the abstract. It is when it works, for whom, and at what dose. So the mechanism is not in question. What is in question, and what almost no consumer article handles honestly, is why the human cognitive trials keep disagreeing with each other. The short answer is that most of them tested well-rested, well-fed, young omnivores whose brains were already energy-sufficient, using doses derived from muscle research that barely move brain creatine at all. When you test the mechanism where the mechanism actually applies, the signal shows up. When you test it where there is no energy deficit to buffer, it does not. That is not a failed hypothesis. That is a hypothesis behaving exactly as predicted.

There is also a second category error, and it is the one that trips up the people who do take creatine for their brain: treating the brain as though it were simply a smaller, softer muscle. It is not. It has its own synthesis machinery, its own transporter bottleneck at the blood-brain barrier, and a saturation curve that looks nothing like skeletal muscle. Dose accordingly, or do not bother.

What Your Brain Actually Costs to Run

Start with the bill. Biophysical modeling of grey matter energetics, work built on the framework Attwell and Laughlin published in 2001, attributes roughly 47 percent of activity-dependent ATP consumption to action potentials and about 34 percent to postsynaptic glutamatergic signaling. Most of the remainder goes to maintaining resting membrane potential.

The single largest line item is the sodium-potassium ATPase, the pump that restores ionic gradients after every spike and every synaptic event. Estimates consistently put it at roughly half of total brain ATP consumption at baseline. A single neuronal action potential is estimated to cost on the order of 700 million ATP molecules. Thinking is not a metaphorically expensive activity. It is a literally expensive one, billed in phosphate.

Here is the constraint that makes creatine matter: ATP cannot be stockpiled. Even in brain cells, cells hold only a few seconds' worth, and ATP diffuses poorly through cytoplasm. A neuron cannot keep a large ATP reserve near the ion pumps that need it, and it cannot wait for oxidative phosphorylation to catch up on a millisecond timescale. It needs something that can be stored, moved, and converted back to ATP instantly, right where the demand is.

That is what phosphocreatine is for.

The Phosphocreatine Shuttle: A Brain Energy Buffer in Space and Time

Creatine kinase catalyzes a reversible reaction: it moves a phosphate group between ATP and creatine. Near the mitochondria, mitochondrial creatine kinase takes freshly made ATP and loads its phosphate onto creatine, producing phosphocreatine. Phosphocreatine then diffuses through the cytosol, far more readily than ATP does, to the places where energy is being spent. At those sites, cytosolic creatine kinase runs the reaction backward and regenerates ATP locally, on demand, directly supporting brain energy metabolism.

This does two distinct jobs. It buffers in space, connecting mitochondria to distant, pump-dense microdomains that ATP diffusion alone could not supply. And it buffers in time, sustaining ATP through demand spikes before oxidative phosphorylation and glycolysis can respond.

Cell-culture work makes the sequence explicit. In cultured astrocytes, under any condition that impaired ATP regeneration, phosphocreatine fell before ATP did. The buffer drains first, which is precisely what a buffer is supposed to do. Creatine supplementation in those same cells doubled the phosphocreatine-to-ATP ratio and improved the cells' capacity to absorb transient energy shortfalls.

The system is also cell-type specific in a way that matters. Brain-type cytosolic creatine kinase predominates in astrocytes; mitochondrial creatine kinase is essentially neuron-specific. And creatine kinase flux in healthy human brain is reportedly faster than oxidative phosphorylation itself, which is the strongest single argument for its role as the first responder to a spike in demand.

Where Your Creatine Comes From

An adult turns over roughly 1 to 2 grams of creatine per day, lost as creatinine in urine. That has to be replaced from two sources.

The first is diet. Creatine is found almost exclusively in animal muscle tissue. An omnivore typically takes in about 1 to 2 grams daily from meat and fish. A vegetarian takes in a small fraction of that, often under 0.3 grams.

The second is endogenous synthesis, and this is where the brain diverges sharply from muscle. Creatine is synthesized from amino acids, and two enzymes do the work: AGAT (arginine:glycine amidinotransferase) converts arginine and glycine to guanidinoacetate, and GAMT (guanidinoacetate methyltransferase) methylates that intermediate into creatine. Skeletal muscle relies overwhelmingly on circulating creatine taken up from the blood. The brain does not. AGAT and GAMT are both expressed throughout neurons, astrocytes, and oligodendrocytes in rodent and human brain tissue, with oligodendrocytes showing the highest co-expression.

The arrangement is genuinely cooperative. Because AGAT and GAMT are often expressed in different cell populations within the same region, guanidinoacetate has to be handed off between cells, a transfer thought to run through the SLC6A8 transporter. Brain creatine synthesis is an intercellular process, not a single-cell one.

The functional proof that this matters is SLC6A8 creatine transporter deficiency, an X-linked disorder in which creatine cannot be transported into brain tissue. Affected children present with intellectual disability, seizures, and speech delay, and their brain MRS spectra show a near-absent creatine peak. Oral creatine does not fix it, because the transporter that would carry it across is the thing that is broken. Brain creatine is not optional. It is load-bearing for normal cognition.

Same molecule, two very different tissues. Skeletal muscle takes creatine up readily and saturates within days. The blood-brain barrier admits it through a single transporter that astrocytic end-feet largely cover, so brain creatine rises far less and takes weeks.

Why the Brain Is Not the Muscle

This is the section that explains most of the confusion in the literature, and most of the disappointment in people who took 5 grams a day for a month and felt nothing.

SLC6A8, the sodium- and chloride-dependent creatine transporter, is expressed on neurons, oligodendrocytes, and the microcapillary endothelial cells that form the blood-brain barrier. It is notably absent from astrocytes, including the astrocytic end-feet that wrap those same capillaries. That creates a physical bottleneck: peripheral creatine can only enter brain parenchyma through the capillary surface that astrocytic processes do not cover.

Rodent kinetic studies put the blood-brain barrier's affinity for creatine transport roughly 10 to 40 times lower than transport into skeletal muscle. Combine an inefficient import route with a tissue that manufactures much of its own supply, and you get the central asymmetry:

Muscle creatine can rise about 20 percent and saturate within days. Brain creatine rises about 5 to 10 percent at best, and takes weeks.

There is also evidence the brain actively defends its setpoint, downregulating endogenous synthesis in response to an exogenous supply. The brain is not a sponge. It is a regulated compartment that has to be persuaded.

What the Human Imaging Data Shows

Magnetic resonance spectroscopy is the only way to see brain creatine directly in a living person, making it central to studying brain health effects, and it is the reason this topic deserves better than supplement-blog treatment.

Dechent and colleagues, 1999. Twenty grams per day for four weeks raised total brain creatine 8.7 percent, with the thalamus responding most (14.6 percent) and grey matter least (4.7 percent). A single 20 gram dose alone did almost nothing.

The landmark study is Dechent and colleagues (1999, American Journal of Physiology). Twenty grams per day for four weeks raised total brain creatine 8.7 percent, with striking regional variation: 14.6 percent in the thalamus, 11.5 percent in white matter, and only 4.7 percent in grey matter. A single 20 gram dose alone produced a non-significant rise. The four weeks, not the dose alone, did the work. The increase fully reversed within three months of stopping.

A multinuclear MRS study by Lyoo and colleagues (2003) found an 8.1 percent rise in brain creatine on a loading-then-maintenance protocol, with phosphocreatine itself rising only 3.4 percent. Those imaging findings speak to brain creatine levels and brain energy, not just blood or muscle changes.

The failures are equally informative. Solis and colleagues (2017, Journal of Applied Physiology) gave 0.3 g/kg/day, roughly 25 grams, for seven days across children, adults, and the elderly. Muscle phosphocreatine rose. Brain phosphocreatine did not move, ranging from minus 0.7 to plus 3.9 percent. Same subjects, same protocol, two completely different tissue responses. If you want one study that proves the brain is not the muscle, that is the one.

Two findings break the "weeks of loading" rule, and both do it under stress. In the Smith and colleagues (2025) University of Kansas pilot, 20 grams per day for eight weeks in 20 patients with Alzheimer's disease raised brain creatine in 85 percent of participants, averaging 11 percent. And in Gordji-Nejad and colleagues (2024, Scientific Reports), a single dose of 0.35 g/kg, roughly 30 grams, given during 21 hours of sleep deprivation, shifted phosphocreatine-to-inorganic-phosphate ratios, ATP, and intracellular pH within hours, peaking around four hours and persisting up to nine.

That last result reframes the whole uptake question. Under metabolic stress, creatine administration may alter brain bioenergetics more rapidly, when neuronal energy demand is high, than it does in a rested brain. The stressed brain lets it in.

What the Cognitive Trials Actually Show About Cognitive Function

Ranked by methodological strength, here is the honest state of the evidence on the effects of creatine supplementation across different cognitive domains. Most evidence comes from randomized controlled trials, though study quality and outcome measures vary.

Sleep deprivation: the most reproducible finding

This is where the signal is cleanest, because it is where the mechanism is most clearly engaged. The Gordji-Nejad 2024 trial found reduced subjective fatigue and significantly shorter task times, with processing speed improving 29.1 percent on the language task, 24.0 percent on the numeric task, and 16.0 percent on the logic task, alongside a 10.3 percent gain in word memory accuracy, all tracking with the measured bioenergetic changes. McMorris and colleagues (2006, Psychopharmacology) found nothing at 6 or 12 hours of sleep deprivation, then a clear preservation of working memory, reaction time, and processing speed at 24 hours. A companion 2007 trial in Physiology & Behavior found benefits on forward and backward spatial recall and long-term memory under 18 to 36 hours of deprivation, with the executive-function effect emerging only at the 36 hour mark.

Notice the pattern. The benefit scales with the severity of the energy stress. That is a dose-response relationship, just not in the dimension people usually look at.

Hypoxia

Turner, Byblow and Gant (2015, Journal of Neuroscience) ran a randomized crossover trial in 15 healthy adults: creatine loading or placebo, each followed by 90 minutes of breathing 10 percent oxygen. Hypoxia impaired multiple cognitive domains. Creatine significantly restored complex attention and increased corticomotor excitability measured by transcranial magnetic stimulation. Effects on composite memory and overall neurocognitive index were inconclusive. A partial rescue, in the specific domain the mechanism predicts, with a physiological corroborating measure.

Aging

The Prokopidis and colleagues (2023, Nutrition Reviews) meta-analysis of memory outcomes found a pooled standardized mean difference of 0.29, driven almost entirely by age. In adults aged 66 to 76, the effect size was 0.88. In adults aged 11 to 31, it was 0.03. That is not a modest gradient. That is two different phenomena sharing a name. Some analyses also report cognitive benefits across adults aged 18 to 60 years, but the effect is far smaller than in older adults.

The mechanistic reading is straightforward: the aging brain requires more energy to complete the same cognitive task, endogenous creatine synthesis declines, and mitochondrial efficiency falls. Reserve capacity that a 25 year old has in surplus is exactly what a 72 year old is short of.

Disease states

The Kansas Alzheimer's pilot reported significant gains in fluid cognition, working memory, and executive function alongside the measured 11 percent rise in brain creatine. It is open-label, single-arm, and uncontrolled, which means it establishes feasibility and target engagement rather than efficacy. It should be read as a reason to run the real trial, not as a result.

In pediatric traumatic brain injury, Sakellaris and colleagues (2006, Journal of Trauma) gave 0.4 g/kg/day for six months to 39 children with severe TBI, starting within four hours of injury. The creatine group showed improvements in cognition, behavior, self-care and communication, with shorter post-traumatic amnesia and ICU stay. Open-label, not placebo-controlled, and in children. No adult TBI trial has been published.

Why Some Trials Found Nothing

This is the section the affiliate articles leave out, and it is the most useful one in this piece. The null results are not noise to be explained away. Read correctly, they are the strongest confirmation that the effects of creatine fit the mechanism the model predicts.

The dose was a muscle dose

Rawson and colleagues (2008) gave 0.03 g/kg/day for six weeks, no loading, to 22 healthy young adults and found nothing on any measure. The paper is titled, plainly, "Creatine supplementation does not improve cognitive function in young adults." Two design choices explain it: a dose well below anything shown to raise brain creatine, in a population with no energy deficit to correct.

The dose was not the problem, the population was

Moriarty and colleagues (2023, Brain Sciences) ran the dose-response study people had been asking for: 10 or 20 grams per day for six weeks in healthy young adults. No cognitive improvement, no change in prefrontal cortex oxygenation. That is a genuinely important negative. It tells you that in a rested, well-fed, young brain, more creatine is not the missing variable. There was no deficit to buffer, even though creatine may still show cognitive enhancing properties under metabolic stress.

The stressor was too mild

A sleep-restriction trial using a single night of three hours in bed, after seven days of 20 grams per day loading, found no cognitive, mood, or vigilance benefit at all. Set against McMorris, where the effect only appeared at 24 to 36 hours, the reading is that one short night is not enough metabolic stress to expose the buffer.

The test was insensitive

Alves and colleagues (2013) studied 56 women aged 60 to 80 on a loading-plus-maintenance protocol for 24 weeks and found no effect on any measure, but the primary instrument was the Mini Mental State Examination. Across this entire literature, no study assessing global cognition by MMSE has found an effect. That is a screening tool for dementia and global cognitive function with a hard ceiling in cognitively intact people. It is the wrong instrument for detecting a subtle bioenergetic effect, and using it guarantees a null, because subtle changes in other cognitive domains are exactly what the MMSE is built to miss.

The statistics were wrong, and it was caught

This one deserves to be stated plainly rather than buried. Later systematic review work and commentary identified the same statistical issue. Two influential meta-analyses reporting positive pooled memory effects, Xu and colleagues (2024, Frontiers in Nutrition) and the Prokopidis 2023 analysis, contained a unit-of-analysis error: multiple non-independent cognitive outcomes from the same participants were pooled as though they were independent, which artificially inflates sample size and precision. The Prokopidis paper drew a letter to the editor and an authors' reply in Nutrition Reviews confirming that when the double-counting was corrected and the pooled standardized mean differences were recalculated, the overall memory effect was no longer statistically significant, with the older-adult subgroup the exception that survived. A 2026 commentary in Frontiers in Nutrition then applied the same critique to the Xu analysis. This is a problem of statistical method and interpretation, not evidence of publication bias.

Separately and independently, the European Food Safety Authority (2024) evaluated a proposed creatine-and-cognition health claim and concluded that a cause-and-effect relationship has not been established. That is a formal regulatory rejection, and anyone writing honestly about this compound has to say so.

My read: the pooled "creatine improves memory in healthy adults" headline does not survive scrutiny. The narrower claims do. Creatine raises brain creatine, measurably, at adequate doses. It protects cognition under sleep deprivation and hypoxia in controlled trials. It shows a large and statistically durable effect in older adults. Those are three defensible claims, and they are more interesting than the overstated one.

The Vegetarian Question Is More Complicated Than You Have Been Told

The standard version goes: vegetarians eat no creatine, so they start depleted, so they respond more. It is a clean story with a clean mechanism, and it is repeated everywhere.

The supporting evidence is real. Rae and colleagues (2003, Proceedings of the Royal Society B) ran a double-blind placebo-controlled crossover trial in 45 young adult vegetarians, 5 grams per day for six weeks. Backward digit span and Raven's matrices under time pressure both improved significantly, p less than 0.0001. Benton and Donohoe (2011, British Journal of Nutrition) tested 128 young women, vegetarians and omnivores, on 20 grams per day for five days: memory improved in the vegetarians and not the omnivores, within the same trial.

Now the complications, which matter.

First, the largest trial to date, Sandkühler and colleagues (2023, BMC Medicine), enrolled 123 participants on 5 grams per day for six weeks and found no greater benefit in vegetarians. The effect was, if anything, non-significantly smaller. The authors noted that the earlier positive trial tested many cognitive tasks, which raises false-positive risk.

Second, and more fundamental, the premise may be wrong. A cross-sectional MRS study in the British Journal of Nutrition asked directly whether vegetarians have depleted brain creatine. They do not. Plasma, serum, red cell and muscle creatine are all lower in vegetarians, as expected. Brain creatine is comparable. The brain's own synthesis machinery appears to defend its setpoint regardless of dietary intake.

That is exactly what you would predict from the AGAT and GAMT biology described earlier, and it is why I am not willing to sell the vegetarian story as settled. Vegans may be a genuinely different case, since they have zero dietary creatine and, if B12 status is poor, potentially impaired methylation for GAMT. That is plausible. It is not demonstrated.

Consistency matters more than timing. No cognitive trial has shown that when you take creatine changes the outcome, and brain stores build over weeks rather than hours.

Dosing for the Brain: Creatine Supplementation

Everything above converges on one practical point: the number on the back of most creatine tubs was derived from muscle research.

Three to five grams per day is a well-supported dose for skeletal muscle saturation, muscle strength, lean mass, and exercise performance. It is also the dose with the deepest long-term safety record, and for most people it is the correct place to start and stay. What it is not is a dose demonstrated to raise brain creatine. The human imaging studies that consistently moved brain creatine used 20 grams per day for four or more weeks, or a large weight-scaled acute dose under stress. Reviews synthesizing this literature converge on roughly 20 grams per day or 0.3 g/kg/day for short periods, or above 4 grams per day sustained for several months, as what is likely required in healthy individuals.

Clinical populations appear to respond at lower doses, likely because disease-driven energy deficits increase uptake: 4 grams per day raised brain phosphocreatine in treatment-resistant depression and in post-COVID fatigue, and 16 grams per day raised it 8.3 percent in ME/CFS.

This is why the recommendation in brain-focused practice has moved over the last two years. The old default of 5 grams was inherited from goals tied to athletic performance and muscle mass rather than brain-specific outcomes, and repeated until it became the number on every label. As the brain imaging data accumulated, the practical target for cognitive purposes shifted upward, and 15 to 20 grams per day is now where most of the people reading this literature closely have landed. That is not a fringe position. It is what the studies that actually measured brain creatine were dosing.

The Honest Timeline

Brain creatine accumulates slowly. Anyone promising you a noticeable cognitive shift on day three is selling something. Here is what the imaging and trial data actually support.

TODAY
Nothing perceptible, unless you are acutely sleep deprived, in which case the single-high-dose data suggests a window of benefit peaking around four hours and fading by nine. That is a rescue protocol, not a daily strategy.

THIS WEEK
Muscle stores approach saturation. Expect a small weight increase from intracellular water, typically one to three pounds. This is not fat and it is not bloating. Brain creatine has barely moved.

THIS MONTH
The window in which brain creatine becomes measurable on MRS at adequate doses. Dechent found 8.7 percent at four weeks. If you are going to notice anything subjectively, this is roughly when, and it will most likely show up on the bad days rather than the good ones: less degradation when you are underslept, under prolonged cognitive load, dealing with mental fatigue, or past hour nine of demanding work.

LONG TERM
Eight weeks and beyond is where the clinical trials that found cognitive effects were run. The strongest case for staying on it indefinitely is preventive rather than acute: reserve capacity for a brain whose energy demands rise, and whose synthetic capacity falls, with every decade. Stop and brain creatine returns to baseline within about three months.

Safety, and the Myths That Will Not Die

Creatine is among the most extensively studied compounds in the supplement literature, and the safety data is unusually good.

A 2025 analysis in the Journal of the International Society of Sports Nutrition pooled 685 clinical trials covering 12,839 participants and found no significant difference in side-effect frequency between creatine and placebo: 4.60 percent versus 4.21 percent. Doses up to 30 grams per day for as long as five years have been tolerated without evidence of organ damage.

Kidneys

This is the most persistent myth and it rests on a measurement artifact. Creatine supplementation raises serum creatinine, because creatinine is creatine's breakdown product. Since estimated GFR is calculated from serum creatinine, your eGFR appears to fall. When kidney function is measured directly, by chromium-EDTA clearance rather than estimated from creatinine, glomerular filtration rate does not change. This holds across healthy trained adults, postmenopausal women, people with type 2 diabetes, and even a documented case in a patient with a single kidney.

The practical implication is worth knowing before your next physical: tell your physician you take creatine, because your eGFR may read artificially low. Cystatin C is the better marker in creatine users.

Hair loss

The entire concern traces to a single 2009 study in South African rugby players reporting a 56 percent rise in DHT during high-dose loading. DHT stayed within the normal physiological range, and hair was never assessed. Of twelve subsequent trials measuring testosterone, ten found no significant increase. A 2025 randomized placebo-controlled 12-week trial measured DHT, the DHT-to-testosterone ratio, and objective follicle health by trichogram and photographic imaging at 5 grams per day, and found no differences. That is the first direct test of the claim, and it did not support it.

Water retention and GI upset

The early weight gain is intracellular water inside muscle cells, not subcutaneous fluid. It does not make you look puffy. GI discomfort is dose-related and largely avoidable: keep any single dose at or below 5 grams and split larger daily totals.

What Creatine Will Not Do

Being useful about a compound means being clear about its ceiling.

It will not make a rested, well-fed, healthy young adult smarter, and it is not a general tool for improving cognitive function in rested young adults. Moriarty ran that experiment properly at 10 and 20 grams per day and found nothing. It will not raise IQ, and it will not produce the acute, felt sharpening that people expect from stimulants. Effect sizes in the most favorable meta-analyses sit around 0.3, which in plain language is small, and the corrected pooled analysis puts even that in question outside older adults.

It will not substitute for sleep. The sleep-deprivation trials show partial preservation of specific functions under acute deprivation. Partial. That is a mitigation for a bad night, not a license for a bad habit.

It will not treat Alzheimer's disease. One open-label pilot in 20 people establishes feasibility and nothing more. It will not fix brain fog driven by an undiagnosed metabolic, hormonal, or sleep disorder. Community reports of dramatic, near-total brain fog resolution substantially exceed anything measured under controlled conditions, and unblinded self-report cannot separate a real effect from expectation.

One note on scope, since I get this question constantly: this article is about the central nervous system, where the phosphocreatine system is well characterized and human imaging exists. The peripheral nerve literature on creatine is essentially empty. Peripheral nerves are metabolically demanding tissue and the mechanistic reasoning is tempting, but reasoning is not evidence, and I will not extend a central-nervous-system finding to peripheral nerve on plausibility alone.

Frequently Asked Questions

Does creatine actually improve memory?

In older adults, the evidence is reasonably strong. Meta-analysis found a large effect on memory function in adults aged 66 to 76, and that effect survived a statistical correction that eliminated the overall pooled effect. In young healthy adults, the honest answer is no. Multiple randomized trials, including a proper dose-response study at 10 and 20 grams per day, found nothing.

How much creatine should I take for brain benefits?

More than the tub says. Many creatine supplements list 5 grams per day, which is the well-established dose for muscle and the right general-health baseline, but for brain-specific effects the imaging studies point to 20 grams per day, split into four 5 gram doses, sustained for at least four to eight weeks. That is the dose that reliably raised measurable brain creatine in the MRS trials, and it is where the field has moved as that data has accumulated. Discuss it with your physician before going above 5 grams, particularly if you have any kidney disease.

How long does creatine take to work for the brain?

Weeks, not days. Muscle saturates in about a week. Brain creatine takes roughly four weeks to become measurable on imaging, and the cognitive trials that found effects generally ran six to eight weeks or longer. The single exception is acute sleep deprivation, where a large single dose has produced measurable changes within hours.

Does creatine help with brain fog?

There is no controlled trial of creatine for brain fog as such, because brain fog is a symptom with many causes rather than a diagnosis. What the trials do show is that creatine preserves brain function under specific measurable energy stresses: sleep deprivation, low oxygen, and aging. If your fog has an energetic component, that is the mechanism by which it might help. If it is driven by thyroid disease, anemia, sleep apnea, or insulin resistance, creatine is not the answer and looking for the cause is.

Do vegetarians benefit more from creatine?

Contested. Two trials found greater memory benefit in vegetarians, but the largest randomized trial to date found no vegetarian advantage, and MRS imaging shows vegetarians do not actually have depleted brain creatine despite clearly lower blood and muscle levels. Vegetarians have a stronger case for supplementing on muscle and general-health grounds than on cognitive ones.

Is creatine safe for the kidneys?

In people with healthy kidneys, yes. Trials using direct clearance measurement rather than creatinine-based estimates show no change in glomerular filtration rate at 5 to 20 grams per day for up to two years. Creatine does raise serum creatinine, which makes estimated GFR read falsely low, so tell your physician you take it. If you have existing kidney disease, that is a conversation to have with your nephrologist first.

Which form of creatine is best for the brain?

Monohydrate. It is the only form with human brain imaging or cognitive trial data behind it. No alternative form has outperformed it even in the far better studied muscle literature, and paying more for a novel form buys you less evidence, not more. What matters is that it is micronized monohydrate with nothing else in the tub, whoever you buy it from.

This content is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Individual results vary. Always consult a qualified healthcare provider regarding your individual medical situation.